Acadia Healthcare Company, Inc.
NASDAQ:ACHCMedical - Care Facilities
+$1.14 today
- Market cap
- $3.49B
- Beta
- 0.69
- P/E (TTM)
- -2.0
- EPS (TTM)
- -$12.23
Volume 1.52M
Average 2.82M
ACHC Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Acadia Healthcare Company, Inc.NASDAQ: ACHC
Accounts Receivables · Q3 FY2026 · quarter ended Sep 2026
Accounts receivables grows, but more slowly than its trailing trend
Q3 FY2026 accounts receivables of $30.64M (cash outflow) rose 37.4% year over year, behind the +52.8% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at +21.4% a year.
Context
- Accounts receivables amounted to 2.3% of revenue in FY2025, up 2.2 pp from a year earlier.
- Accounts receivables grew in size in 1 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +37.4% toward the trailing-twelve-month pace of +52.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (75.02M) USD
- Year-over-year change
- -3121.3%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (75.02M) | -3121.3% |
| FY2024 | 2024-12-31 | (2.33M) | +94.0% |
| FY2023 | 2023-12-31 | (39.01M) | +7.1% |
| FY2022 | 2022-12-31 | (41.98M) | -1814.8% |
| FY2021 | 2021-12-31 | 2.45M | — |
Accounts Receivables vs competitors
How ACHC compares with its peers on the latest reported figures
- ACHC's LTM Sep 2026 accounts receivables of $70.85M is the 2nd largest of the 3 companies compared; the peer median is $171.94M.
- Its year-over-year change of +52.8% is the 2nd highest of 3, against a peer median of +124.3%.
- Accounts receivables amounts to 2.1% of revenue for ACHC, versus a peer median of 1.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $363.26M | +297.2% | +7.2% | 2.0% | |
| LTM Sep 2026 | $70.85M | +52.8% | +21.4% | 2.1% | |
| LTM Jun 2026 | $19.37M | -48.7% | — | 1.2% | |
| Peer median (excluding ACHC) | $171.94M | +124.3% | +7.2% | 1.6% | |
Competitors are the stored peer set for ACHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 195.56M | 280.03M | (15.66M) | 264.48M | (1.09B) |
| Depreciation & Amortization | 106.72M | 117.77M | 132.35M | 149.6M | 189.25M |
| Deferred Income Tax | 11.77M | 16.55M | (93.98M) | 67.71M | 1.09M |
| Stock-Based Compensation | 37.53M | 29.64M | 32.29M | 37.11M | 31.71M |
| Change in Working Capital | (43.5M) | (69.35M) | 6.63M | (405.89M) | (8.67M) |
| Accounts Receivables | 2.45M | (41.98M) | (39.01M) | (2.33M) | (75.02M) |
| Inventory | (13.99M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 6.16M | 5.17M | 17.4M | (420.89M) | 14.88M |
| Other Working Capital | (38.13M) | (32.55M) | 28.24M | 17.34M | 51.48M |
| Other Non-Cash Items | 66.4M | 5.94M | 400.71M | 16.68M | 1.01B |
| Operating Cash Flow | 374.48M | 380.57M | 462.34M | 129.69M | 131.9M |
| Capital Expenditures | (244.81M) | (296.15M) | (424.13M) | (690.39M) | (571.81M) |
| Acquisitions (Net) | 1.37B | (9.51M) | (349K) | (53.55M) | 24.32M |
| Purchases of Investments | (84.8M) | 0 | 0 | 0 | 0 |
| Sales of Investments | 244.81M | 0 | 0 | 0 | 0 |
| Other Investing Activities | (269.58M) | (174K) | 27.26M | 7.46M | (90K) |
| Investing Cash Flow | 1.02B | (305.83M) | (397.22M) | (736.48M) | (547.58M) |
| Debt Repayment | (1.64B) | (113.59M) | (16.25M) | 583.67M | 532.34M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (5.73M) | 0 | (52.53M) | (8.55M) | (50.03M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 5.58M | 2.69M | 6.09M | 7.9M | (9.69M) |
| Financing Cash Flow | (1.64B) | (110.9M) | (62.7M) | 583.02M | 472.61M |
| Effect of Forex Changes | 4.07M | 0 | 0 | 0 | 0 |
| Net Change in Cash | (244.88M) | (36.16M) | 2.42M | (23.77M) | 56.94M |
| Free Cash Flow | 129.67M | 84.42M | 38.21M | (560.69M) | (439.91M) |
Acadia Healthcare Company, Inc.
NASDAQ:ACHC
Intrinsic Alpha fair value
Locked
Current Price
$37.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.